← Leaderboards
Daniel B Vigneron
University Of California, San Francisco
$43,424,992
Attributed
$63,573,260
Total exposure
32
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$97,982,403 · 34
By mechanism
R01$41,593,082 · 13
P41$24,690,704 · 11
P01$19,261,252 · 5
U01$9,804,472 · 2
S10$1,717,144 · 1
R21$915,749 · 2
Top collaborators
- John Kurhanewicz23 shared
- Susan M Chang14 shared
- Robert A Bok10 shared
- Ralph Eugene Hurd10 shared
- Jeremy William Gordon9 shared
- Rahul Aggarwal5 shared
- Pamela N Munster5 shared
- Daniel Martin Ruscitto3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- David O Okonkwo$3,047,456
- Joseph Thomas Giacino$4,115,013
- Ralph Eugene Hurd$2,412,854
- Robert A Bok$3,250,145
- Bruce L Miller$34,542,477
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingImageDesignImaging TechniquesMetabolicPre-ClinicalResearch PersonnelMonitorClinical ResearchMolecular ImagingMalignant Neoplasm Of ProstateImaging ModalityTranslatingMalignant NeoplasmsResolutionTranslationsTechnologyResponsePyruvateCancer PatientSiteFutureInstrumentationClinical Trials
Grant awards (155)
Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management$2,654,906
P01 · FY2025 · CA
Hyperpolarized MRI Technology Resource Center$1,211,237
P41 · FY2025 · EB · contact PI
Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring$669,724
R01 · FY2025 · CA · contact PI
Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients$665,957
R01 · FY2025 · CA · contact PI
Technology Development for Polarizer and Detector Instrumentation$317,598
P41 · FY2025 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$175,801
P41 · FY2025 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$71,847
P41 · FY2025 · EB · contact PI
Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management$2,654,906
P01 · FY2024 · CA
Hyperpolarized MRI Technology Resource Center$1,211,237
P41 · FY2024 · EB · contact PI
Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring$636,237
R01 · FY2024 · CA · contact PI
Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients$632,659
R01 · FY2024 · CA · contact PI
Technology Development for Polarizer and Detector Instrumentation$317,598
P41 · FY2024 · EB · contact PI
Administrative Supplement for the Optimization, Calibration, and Dissemination of Carbon-13 Imaging Phantoms$199,747
P41 · FY2024 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$199,747
P41 · FY2024 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$175,801
P41 · FY2024 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$71,846
P41 · FY2024 · EB · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,382,735
P01 · FY2023 · CA
Hyperpolarized MRI Technology Resource Center$1,211,237
P41 · FY2023 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,201,901
U01 · FY2023 · EB · contact PI
Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring$656,329
R01 · FY2023 · CA · contact PI
Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients$652,638
R01 · FY2023 · CA · contact PI
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients$639,785
U01 · FY2023 · CA · contact PI
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of Glioma$562,291
P01 · FY2023 · CA · contact PI
Supplement for Development and Translation of Specialized Hyperpolarized C-13 MRI Methods for Alzheimer's Disease$403,750
U01 · FY2023 · EB · contact PI
Technology Development for Polarizer and Detector Instrumentation$317,596
P41 · FY2023 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$175,799
P41 · FY2023 · EB · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$85,963
P01 · FY2023 · CA
Admin-Core-001$84,577
P01 · FY2023 · CA
Hyperpolarized MRI Technology Resource Center$71,848
P41 · FY2023 · EB · contact PI
Admin-Core-001$12,280
P01 · FY2023 · CA
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of Glioma$12,280
P01 · FY2023 · CA · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,278,799
P01 · FY2022 · CA
Hyperpolarized MRI Technology Resource Center$1,711,237
P41 · FY2022 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,203,327
U01 · FY2022 · EB · contact PI
Technology Development for Polarizer and Detector Instrumentation$747,638
P41 · FY2022 · EB · contact PI
Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring$656,329
R01 · FY2022 · CA · contact PI
Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients$652,638
R01 · FY2022 · CA · contact PI
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients$639,782
U01 · FY2022 · CA · contact PI
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of Glioma$506,357
P01 · FY2022 · CA · contact PI
Hyperpolarized MRI Technology Resource Center$175,799
P41 · FY2022 · EB · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$85,963
P01 · FY2022 · CA
Admin-Core-001$82,817
P01 · FY2022 · CA
Hyperpolarized MRI Technology Resource Center$71,848
P41 · FY2022 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$38,229
U01 · FY2022 · EB · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,277,604
P01 · FY2021 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,180,441
U01 · FY2021 · EB · contact PI
Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring$669,448
R01 · FY2021 · CA · contact PI
Hyperpolarized C-13 MRI Techniques to Monitor Radiation Therapy Response in Prostate Cancer Patients$662,643
R01 · FY2021 · CA · contact PI
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients$652,841
U01 · FY2021 · CA · contact PI
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$600,901
R01 · FY2021 · CA
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of Glioma$496,658
P01 · FY2021 · CA · contact PI
Diversity Supplement: 5P01CA118816 Project 1$87,717
P01 · FY2021 · CA
Admin-Core-001$87,717
P01 · FY2021 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$85,819
U01 · FY2021 · EB · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,238,345
P01 · FY2020 · CA
Upgrade of an Obsolete 3.35T DNP Polarizer to enable new HP C-13 Technology Development$1,717,144
S10 · FY2020 · OD · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,204,018
U01 · FY2020 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$1,188,178
P41 · FY2020 · EB · contact PI
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$671,381
R01 · FY2020 · CA
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients$651,831
U01 · FY2020 · CA · contact PI
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of Glioma$511,629
P01 · FY2020 · CA · contact PI
TR&D1: Development of Improved DNP Methodology and HP MR Acquisition Techniques$385,130
P41 · FY2020 · EB · contact PI
Admin-Core: Hyperpolarized MRI Technology Resource Center$140,689
P41 · FY2020 · EB · contact PI
Training-Dissem-001: Hyperpolarized MRI Technology Resource Center$68,613
P41 · FY2020 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$38,229
U01 · FY2020 · EB · contact PI
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma$2,157,708
P01 · FY2019 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,215,003
U01 · FY2019 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$1,188,178
P41 · FY2019 · EB · contact PI
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients$649,516
U01 · FY2019 · CA · contact PI
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING$627,880
R01 · FY2019 · CA
TR&D1: Development of Improved DNP Methodology and HP MR Acquisition Techniques$385,130
P41 · FY2019 · EB · contact PI
Admin-Core: Hyperpolarized MRI Technology Resource Center$140,689
P41 · FY2019 · EB · contact PI
Training-Dissem-001: Hyperpolarized MRI Technology Resource Center$68,613
P41 · FY2019 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$1,188,178
P41 · FY2018 · EB · contact PI
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$657,821
R01 · FY2018 · CA · contact PI
TR&D1: Development of Improved DNP Methodology and HP MR Acquisition Techniques$385,130
P41 · FY2018 · EB · contact PI
Admin-Core: Hyperpolarized MRI Technology Resource Center$140,689
P41 · FY2018 · EB · contact PI
Training-Dissem-001: Hyperpolarized MRI Technology Resource Center$68,613
P41 · FY2018 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$1,188,178
P41 · FY2017 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,185,440
R01 · FY2017 · EB · contact PI
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$657,802
R01 · FY2017 · CA · contact PI
TR&D1: Development of Improved DNP Methodology and HP MR Acquisition Techniques$385,132
P41 · FY2017 · EB · contact PI
Admin-Core: Hyperpolarized MRI Technology Resource Center$140,691
P41 · FY2017 · EB · contact PI
Training-Dissem-001: Hyperpolarized MRI Technology Resource Center$68,611
P41 · FY2017 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$1,688,750
P41 · FY2016 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,185,393
R01 · FY2016 · EB · contact PI
TR&D1: Development of Improved DNP Methodology and HP MR Acquisition Techniques$885,131
P41 · FY2016 · EB · contact PI
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI$712,949
R01 · FY2016 · EB · contact PI
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$655,718
R01 · FY2016 · CA · contact PI
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$620,489
R01 · FY2016 · CA
Admin-Core: Hyperpolarized MRI Technology Resource Center$140,689
P41 · FY2016 · EB · contact PI
Training-Dissem-001: Hyperpolarized MRI Technology Resource Center$68,613
P41 · FY2016 · EB · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,162,611
R01 · FY2015 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$958,499
P41 · FY2015 · EB · contact PI
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI$698,454
R01 · FY2015 · EB · contact PI
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$641,305
R01 · FY2015 · CA · contact PI
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$619,505
R01 · FY2015 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,147,784
R01 · FY2014 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$967,957
P41 · FY2014 · EB · contact PI
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI$685,657
R01 · FY2014 · EB · contact PI
Translating HP 13C MRI as a Novel Paradigm for Assessing Drug Target Inhibition$650,008
R01 · FY2014 · CA · contact PI
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$583,254
R01 · FY2014 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$481,279
R01 · FY2014 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,190,965
R01 · FY2013 · EB · contact PI
Hyperpolarized MRI Technology Resource Center$967,097
P41 · FY2013 · EB · contact PI
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI$704,365
R01 · FY2013 · EB · contact PI
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$563,723
R01 · FY2013 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$495,937
R01 · FY2013 · CA
Hyperpolarized MRI Technology Resource Center$1,048,681
P41 · FY2012 · EB · contact PI
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy$613,774
R01 · FY2012 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$497,610
R01 · FY2012 · CA
Hyperpolarized MRI Technology Resource Center$1,576,106
P41 · FY2011 · EB · contact PI
Development of Improved DNP Methodology and HP MR Acquisition Techniques$630,146
P41 · FY2011 · EB · contact PI
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$555,502
R01 · FY2011 · CA
METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI$427,228
R01 · FY2011 · CA · contact PI
Training Plan$193,132
P41 · FY2011 · EB · contact PI
Morphologic, Metabolic and Functional Prostate Imaging$869,116
R01 · FY2010 · CA · contact PI
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam$582,287
R01 · FY2010 · CA
TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES$528,582
R01 · FY2010 · EB · contact PI
METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI$435,081
R01 · FY2010 · CA · contact PI
MR Diffusion Tensor Imaging of Prostate Cancer$261,115
R01 · FY2010 · CA · contact PI
Hyperpolarized C-13 MR Exploratory Studies of Liver Cancer$134,289
R21 · FY2010 · CA · contact PI
TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES$1,221,350
R01 · FY2009 · EB · contact PI
Morphologic, Metabolic and Functional Prostate Imaging$854,691
R01 · FY2009 · CA · contact PI
TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES$518,373
R01 · FY2009 · EB · contact PI
METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI$429,307
R01 · FY2009 · CA · contact PI
METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI$307,206
R01 · FY2009 · CA · contact PI
MR Diffusion Tensor Imaging of Prostate Cancer$261,115
R01 · FY2009 · CA · contact PI
Hyperpolarized C-13 MR Exploratory Studies of Liver Cancer$235,104
R21 · FY2009 · CA · contact PI
TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES$193,370
R01 · FY2009 · EB · contact PI
Morphologic, Metabolic and Functional Prostate Imaging$832,098
R01 · FY2008 · CA · contact PI
TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES$489,479
R01 · FY2008 · EB · contact PI
METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI$415,964
R01 · FY2008 · CA · contact PI
MR Diffusion Tensor Imaging of Prostate Cancer$261,115
R01 · FY2008 · CA · contact PI
Morphologic, Metabolic and Functional Prostate Imaging$805,297
R01 · FY2007 · CA · contact PI
TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES$471,132
R01 · FY2007 · EB · contact PI
METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI$407,934
R01 · FY2007 · CA · contact PI
MR Diffusion Tensor Imaging of Prostate Cancer$261,115
R01 · FY2007 · CA · contact PI
Morphologic, Metabolic and Functional Prostate Imaging$842,943
R01 · FY2006 · CA · contact PI
MR Diffusion Tensor Imaging of Prostate Cancer$268,913
R01 · FY2006 · CA · contact PI
Metabolic Imaging of the Prostate Using 3D MRSI$386,311
R01 · FY2005 · CA
3D MR SPECTROSCOPIC IMAGING OF THE NEWBORN BRAIN$331,875
R01 · FY2005 · NS
Metabolic Imaging of the Prostate Using 3D MRSI$376,284
R01 · FY2004 · CA
3D MR SPECTROSCOPIC IMAGING OF THE NEWBORN BRAIN$331,875
R01 · FY2004 · NS
3D MR SPECTROSCOPIC IMAGING OF THE NEWBORN BRAIN$413,406
R01 · FY2003 · NS
Metabolic Imaging of the Prostate Using 3D MRSI$413,327
R01 · FY2003 · CA
MR Metabolic Brain Imaging of the Infant Brain$184,375
R21 · FY2003 · NS
Metabolic Imaging of the Prostate Using 3D MRSI$411,989
R01 · FY2002 · CA
3D MR SPECTROSCOPIC IMAGING OF THE NEWBORN BRAIN$410,135
R01 · FY2002 · NS
MR Metabolic Brain Imaging of the Infant Brain$181,905
R21 · FY2002 · NS
Metabolic Imaging of the Prostate Using 3D MRSI$413,674
R01 · FY2001 · CA
3D MR SPECTROSCOPIC IMAGING OF THE NEWBORN BRAIN$326,423
R01 · FY2001 · NS
MR Metabolic Brain Imaging of the Infant Brain$180,076
R21 · FY2001 · NS
3D MR SPECTROSCOPIC IMAGING OF THE NEWBORN BRAIN$80,467
R01 · FY2001 · NS
METABOLIC IMAGING OF THE PROSTATE USING 3D MRSI$330,396
R01 · FY2000 · CA